Skip to main content
. 2022 Jun 4;292(2):243–261. doi: 10.1111/joim.13508

Fig. 2.

Fig. 2

Workflow for guiding a therapeutic decision based on comprehensive genomic and transcriptomic profiling in patients with rare cancers, with courtesy of NCT Heidelberg [135].